Tranexamic acid

氨甲环酸

Report date: 2026/05/26 20:00:28
NME

Base Information

Drug NameTranexamic acid
Drug Alias Name透明酸acide tranexamiqueacidum tranexamicum对氨甲基环己烷甲酸止血环酸 +[19] 
ClassificationSmall molecules
Mechanisms of ActionPlasminogen inhibitors
TargetsPlasminogen
Therapy Area/IndicationsRejection of lung transplantationCoronavirus Disease 2019 (COVID-19)Laryngopharyngitis +[77] 
Global Approved IndicationsHemorrhageMenorrhagia
Approved Indications in ChinaHemorrhage
Original Approved Country/TerritoryJapan
Original Approved Date1965/01/01
Country/TerritoryCzechiaBelgiumCanada +[39] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesDaiichi Sankyo Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCanadian Institutes Of Health Research (Cihr)University Of California San FranciscoUniversity Of Health Sciences Lahore +[45] 
Inactive CompaniesUtah State UniversityThe University Of Texas At San AntonioUniversity of Texas Southwestern Medical Center +[30] 
Active IndicationsRejection of lung transplantationLaryngopharyngitisCognition +[49] 
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)ContusionsTendon Injuries +[28] 

Other Information

ATC CodeB02AA02
Related LinksWikipediaDrugBankKEGG